University Hospital Tuebingen
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1388-01-01
- Employees
- -
- Market Cap
- -
Randomized Trial Investigating Four Nasal CPAP Systems in the Management of Apnea of Prematurity
Not Applicable
Terminated
- Conditions
- First Posted Date
- 2007-06-04
- Last Posted Date
- 2007-08-24
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 16
- Registration Number
- NCT00482040
D3-GHR Polymorphism and Turner Syndrome
Completed
- Conditions
- First Posted Date
- 2007-03-05
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- University Hospital Tuebingen
- Registration Number
- NCT00443144
- Locations
- 🇩🇪
University-Children's Hospital, Tübingen, Germany
Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion
Terminated
- Conditions
- First Posted Date
- 2007-02-14
- Last Posted Date
- 2008-06-09
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 40
- Registration Number
- NCT00435305
- Locations
- 🇩🇪
Universitäsklinikum Tübingen, Klinik für Anästhesiologie und Intensivmedizin, Tübingen, Germany
Pemetrexed in Patients With Soft Tissue Sarcoma
Phase 2
Completed
- Conditions
- First Posted Date
- 2007-01-29
- Last Posted Date
- 2009-02-16
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 54
- Registration Number
- NCT00427466
- Locations
- 🇩🇪
Medical Center II, University of Tuebingen, Tuebingen, Germany
Efficiency of a New Therapy to Treat Stenosis of Coronary Vessels in Comparison With Two Already Admitted Therapies
Phase 3
- Conditions
- First Posted Date
- 2006-11-08
- Last Posted Date
- 2007-05-16
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 204
- Registration Number
- NCT00396929
- Locations
- 🇩🇪
Abteilung Kardiologie und Kreislauferkrankungen, Medizinische Universitätsklinik und Poliklinik III, Universitätsklinikum Tübingen, Tuebingen, Germany
Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease
Phase 1
Terminated
- Conditions
- First Posted Date
- 2006-09-08
- Last Posted Date
- 2014-05-29
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 10
- Registration Number
- NCT00373815
- Locations
- 🇩🇪
Medical Center, Hematology & Oncology, University of Tuebingen, Tuebingen, Germany
Pharmacokinetic Interaction Study Between Budesonide and Metronidazole in Healthy Volunteers
Phase 4
Completed
- Conditions
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2007-12-11
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 12
- Registration Number
- NCT00338910
Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-06-12
- Last Posted Date
- 2008-02-05
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 23
- Registration Number
- NCT00335920
- Locations
- 🇩🇪
Bundeswehrkrankenhaus Ulm, Ulm, Germany
🇩🇪St. Vincentius Kliniken, Klinik für HNO Heilkunde, Karlsruhe, Germany
🇩🇪Department of Otorhinolaryngology, University of Tubingen, Tubingen, Germany
Development of a New Method for Steady-State Measurement of NO Lung Diffusing Capacity in Healthy Subjects
Phase 1
- Conditions
- First Posted Date
- 2006-04-19
- Last Posted Date
- 2007-06-14
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 107
- Registration Number
- NCT00315965
- Locations
- 🇩🇪
University children´s hospital, Tuebingen, Germany
Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma
- First Posted Date
- 2006-03-22
- Last Posted Date
- 2014-05-29
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 14
- Registration Number
- NCT00306111
- Locations
- 🇩🇪
Dept. of Medicine 2, University of Tuebingen, Tuebingen, BW, Germany
© Copyright 2024. All Rights Reserved by MedPath